의료기기 누출 검사 시장 - 규모, 점유율, 성장률, 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of medical device leak testing Market

The global medical device leak testing market is witnessing robust growth, driven by the rising production of medical devices and stringent regulatory requirements for product safety and quality assurance. According to the 2025 report, the market was valued at USD 541.82 million in 2025 and is projected to grow to USD 599.03 million in 2026. By 2034, the market is expected to reach USD 1,714.82 million, registering a strong CAGR of 14.05% during the forecast period (2026-2034). In 2025, Asia Pacific dominated the global market with a 44.40% share, reflecting the region's expanding medical device manufacturing base.

Market Overview

Medical device leak testing is a mandatory quality control procedure used to detect leaks in devices such as catheters, blood bags, implantable devices, ventilators, and other critical equipment. Leak detection ensures product integrity, patient safety, and regulatory compliance before commercialization. Various testing methods are used depending on the device type and application area, including cardiology, urology, orthopedics, and minimally invasive surgery.

The increasing prevalence of chronic diseases worldwide has led to a surge in diagnostic and therapeutic procedures, which in turn has boosted the demand for medical devices. This expanding production volume directly contributes to higher adoption of leak testing systems across manufacturing facilities.

COVID-19 Impact

The COVID-19 pandemic had a positive impact on the medical device leak testing market. During 2020, the demand for ventilators, catheters, and other essential medical equipment surged significantly. Several manufacturers increased production capacity to meet urgent healthcare needs. For instance, Philips doubled its ventilator production capacity in 2020. The higher production volumes resulted in a substantial increase in the number of leak tests performed globally.

Although there was a slight decline in 2021 due to bulk procurement during the peak pandemic phase, overall demand for leak testing solutions remained strong, supporting long-term market expansion.

Market Trends

One of the key trends shaping the market is the growing number of regional leak testing service providers. Due to the high installation and maintenance costs of leak testing systems, many small and mid-sized manufacturers are outsourcing testing services. This shift has led to the emergence of new service providers globally.

Additionally, manufacturers are increasingly launching advanced leak testers with improved automation and integration capabilities to meet evolving production requirements.

Market Growth Drivers

The primary growth driver is the rising production of medical devices worldwide. Increasing cases of cardiovascular, urological, and orthopedic disorders are accelerating the demand for catheters, implantable devices, and surgical equipment.

For example, approximately 90,000 people use catheters in the U.K., and millions of patients globally rely on implantable pacemakers. Expanding manufacturing facilities, such as new catheter production plants, are further increasing the demand for leak testing equipment.

Moreover, the widespread installation of leak testers across manufacturing units-estimated in hundreds of thousands globally-demonstrates strong penetration and growing adoption.

Restraining Factors

Despite strong growth, the market faces challenges due to the high costs associated with leak testing equipment. Advanced systems such as helium and hydrogen-based tracer gas testers require significant investment, limiting adoption among small manufacturers, especially in emerging economies. Installation, calibration, and maintenance expenses further add to operational costs.

Market Segmentation Analysis

By Test Type

The market is segmented into pressure decay, vacuum decay, tracer gas, and others.

The pressure decay segment held the largest share of 43.73% in 2026, driven by its simplicity, automation compatibility, and easy integration into assembly lines. Vacuum decay and tracer gas testing methods are also gaining traction due to improved accuracy and regulatory compliance advantages.

By Application

Based on application, the market includes cardiology, urology, orthopedics, minimally invasive/general surgery, diabetes care, and others.

The urology segment accounted for 30.52% share in 2026, supported by rising catheter usage and urological procedures. Cardiology is also expanding due to growing adoption of pacemakers and implantable devices.

By Product Type

The market is segmented into catheters, blood devices, bags, implantable devices, capital equipment, and others.

The catheters segment dominated with a 33.48% share in 2026, owing to frequent product launches and high global usage rates. Increasing regulatory requirements for pre-market leak validation further strengthen segment growth.

Regional Insights

Asia Pacific

Asia Pacific led the market in 2025 with USD 240.54 million, and the regional market reached USD 267.11 million in 2026. Growth is fueled by expanding medical device production, rising minimally invasive surgeries, and regulatory mandates.

North America

North America continues to grow steadily due to high prevalence of cardiovascular and urological disorders, along with strong presence of major leak testing companies launching advanced technologies.

Europe

Europe is witnessing growth driven by an aging population and increasing orthopedic procedures, boosting demand for reliable leak testing solutions.

Rest of the World

Other regions are experiencing gradual growth due to increasing regulatory awareness and growing R&D investments in medical device manufacturing.

Competitive Landscape

The market is semi-consolidated, with major players such as ATEQ Leaktesting, Cincinnati Test Systems, Pfeiffer Vacuum GmbH, InterTech Development Company, Uson L.P., Zaxis Inc., FasTest, and LACO Technologies. These companies are focusing on product innovation, partnerships, facility expansions, and geographic expansion to strengthen their market position.

Recent developments include facility expansions, product upgrades, and strategic collaborations aimed at enhancing leak detection capabilities and global outreach.

Conclusion

The global medical device leak testing market is positioned for substantial expansion, growing from USD 541.82 million in 2025 to USD 599.03 million in 2026, and projected to reach USD 1,714.82 million by 2034 at a CAGR of 14.05%. Rising medical device production, stringent regulatory standards, increasing chronic disease prevalence, and technological advancements in leak detection systems are the primary forces driving market growth worldwide.

Segmentation By Test Type

• Pressure Decay
• Vacuum Decay
• Tracer Gas
• Others

By Application

• Cardiology
• Urology
• Orthopedics
• Minimally Invasive Surgery/General Surgery
• Diabetes Care
• Others

By Product Type

• Catheters
• Blood Devices
• Bags
• Implantable Devices
• Capital Equipment
• Others

By Region

• North America (By Test Type, Application, Product Type, and Country)
  • U.S.
  • Canada
• Europe (By Test Type, Application, Product Type, and Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Rest of Europe
• Asia Pacific (By Test Type, Application, Product Type, and Country/Sub-region)
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• Rest of the World (By Test Type, Application, and Product Type)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Overview of the Global Medical Device Market, 2025
• 4.2. Healthcare Overview for Key Countries, 2025
• 4.3. Recent Industry Developments - Mergers, Acquisitions & Partnership
• 4.4. Technological Advancements
• 4.5. Impact of COVID-19 on the Market

5. Global Medical Device Leak Testing Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Test Type
  • 5.1.1. Pressure Decay
  • 5.1.2. Vacuum Decay
  • 5.1.3. Tracer Gas
  • 5.1.4. Others
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Cardiology
  • 5.2.2. Urology
  • 5.2.3. Orthopedics
  • 5.2.4. Minimally Invasive Surgery/General Surgery
  • 5.2.5. Diabetes Care
  • 5.2.6. Others
• 5.3. Market Analysis, Insights and Forecast - By Product Type
  • 5.3.1. Catheters
  • 5.3.2. Blood Devices
  • 5.3.3. Bags
  • 5.3.4. Implantable Devices
  • 5.3.5. Capital Equipment
  • 5.3.6. Others
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Rest of the World

6. North America Medical Device Leak Testing Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Test Type
  • 6.1.1. Pressure Decay
  • 6.1.2. Vacuum Decay
  • 6.1.3. Tracer Gas
  • 6.1.4. Others
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Cardiology
  • 6.2.2. Urology
  • 6.2.3. Orthopedics
  • 6.2.4. Minimally Invasive Surgery/General Surgery
  • 6.2.5. Diabetes Care
  • 6.2.6. Others
• 6.3. Market Analysis, Insights and Forecast - By Product Type
  • 6.3.1. Catheters
  • 6.3.2. Blood Devices
  • 6.3.3. Bags
  • 6.3.4. Implantable Devices
  • 6.3.5. Capital Equipment
  • 6.3.6. Others
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Medical Device Leak Testing Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Test Type
  • 7.1.1. Pressure Decay
  • 7.1.2. Vacuum Decay
  • 7.1.3. Tracer Gas
  • 7.1.4. Others
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Cardiology
  • 7.2.2. Urology
  • 7.2.3. Orthopedics
  • 7.2.4. Minimally Invasive Surgery/General Surgery
  • 7.2.5. Diabetes Care
  • 7.2.6. Others
• 7.3. Market Analysis, Insights and Forecast - By Product Type
  • 7.3.1. Catheters
  • 7.3.2. Blood Devices
  • 7.3.3. Bags
  • 7.3.4. Implantable Devices
  • 7.3.5. Capital Equipment
  • 7.3.6. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.4.1. U.K
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Rest of Europe

8. Asia Pacific Medical Device Leak Testing Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Test Type
  • 8.1.1. Pressure Decay
  • 8.1.2. Vacuum Decay
  • 8.1.3. Tracer Gas
  • 8.1.4. Others
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Cardiology
  • 8.2.2. Urology
  • 8.2.3. Orthopedics
  • 8.2.4. Minimally Invasive Surgery/General Surgery
  • 8.2.5. Diabetes Care
  • 8.2.6. Others
• 8.3. Market Analysis, Insights and Forecast - By Product Type
  • 8.3.1. Catheters
  • 8.3.2. Blood Devices
  • 8.3.3. Bags
  • 8.3.4. Implantable Devices
  • 8.3.5. Capital Equipment
  • 8.3.6. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.4.1. Japan
  • 8.4.2. China
  • 8.4.3. India
  • 8.4.4. Rest of Asia Pacific

9. Rest of the World Medical Device Leak Testing Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Test Type
  • 9.1.1. Pressure Decay
  • 9.1.2. Vacuum Decay
  • 9.1.3. Tracer Gas
  • 9.1.4. Others
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Cardiology
  • 9.2.2. Urology
  • 9.2.3. Orthopedics
  • 9.2.4. Minimally Invasive Surgery/General Surgery
  • 9.2.5. Diabetes Care
  • 9.2.6. Others
• 9.3. Market Analysis, Insights and Forecast - By Product Type
  • 9.3.1. Catheters
  • 9.3.2. Blood Devices
  • 9.3.3. Bags
  • 9.3.4. Implantable Devices
  • 9.3.5. Capital Equipment
  • 9.3.6. Others

10. Competitive Analysis

• 10.1. Global Market Share Analysis (2025)
• 10.2. Company Profiles
  • 10.2.1. ATEQ Leaktesting
    • 10.2.1.1. Overview
    • 10.2.1.2. Products
    • 10.2.1.3. SWOT Analysis
    • 10.2.1.4. Recent Developments
    • 10.2.1.5. Strategies
    • 10.2.1.6. financials (Based on Availability)
  • 10.2.2. Zaxis Inc.
    • 10.2.2.1. Overview
    • 10.2.2.2. Products
    • 10.2.2.3. SWOT Analysis
    • 10.2.2.4. Recent Developments
    • 10.2.2.5. Strategies
    • 10.2.2.6. financials (Based on Availability)
  • 10.2.3. FasTest
    • 10.2.3.1. Overview
    • 10.2.3.2. Products
    • 10.2.3.3. SWOT Analysis
    • 10.2.3.4. Recent Developments
    • 10.2.3.5. Strategies
    • 10.2.3.6. financials (Based on Availability)
  • 10.2.4. Inter Tech Development Company
    • 10.2.4.1. Overview
    • 10.2.4.2. Products
    • 10.2.4.3. SWOT Analysis
    • 10.2.4.4. Recent Developments
    • 10.2.4.5. Strategies
    • 10.2.4.6. financials (Based on Availability)
  • 10.2.5. USON, LP.
    • 10.2.5.1. Overview
    • 10.2.5.2. Products
    • 10.2.5.3. SWOT Analysis
    • 10.2.5.4. Recent Developments
    • 10.2.5.5. Strategies
    • 10.2.5.6. financials (Based on Availability)
  • 10.2.6. Pfeiffer Vacuum GmbH
    • 10.2.6.1. Overview
    • 10.2.6.2. Products
    • 10.2.6.3. SWOT Analysis
    • 10.2.6.4. Recent Developments
    • 10.2.6.5. Strategies
    • 10.2.6.6. financials (Based on Availability)
  • 10.2.7. Cincinnati Test Systems
    • 10.2.7.1. Overview
    • 10.2.7.2. Products
    • 10.2.7.3. SWOT Analysis
    • 10.2.7.4. Recent Developments
    • 10.2.7.5. Strategies
    • 10.2.7.6. financials (Based on Availability)
  • 10.2.8. LACO Technologies
    • 10.2.8.1. Overview
    • 10.2.8.2. Products
    • 10.2.8.3. SWOT Analysis
    • 10.2.8.4. Recent Developments
    • 10.2.8.5. Strategies
    • 10.2.8.6. financials (Based on Availability)
  • 10.2.9. Alliance Concept
    • 10.2.9.1. Overview
    • 10.2.9.2. Products
    • 10.2.9.3. SWOT Analysis
    • 10.2.9.4. Recent Developments
    • 10.2.9.5. Strategies
    • 10.2.9.6. financials (Based on Availability)